Sign in to continue:

Tuesday, February 10th, 2026

Minority Shareholders Push for Value Unlock at United Overseas Insurance

Minority Shareholders Push for Value Unlock at United Overseas Insurance: Call for Distribution of Haw Par Shares and Independent Adviser

In a bold move to maximize shareholder value, a group of minority shareholders of United Overseas Insurance (UOI) have proposed two pivotal resolutions to be discussed at the insurer’s upcoming annual general meeting (AGM). These proposals aim to distribute UOI’s substantial holding of 4.27 million shares in healthcare conglomerate Haw Par Corporation to UOI shareholders, along with the appointment of an independent financial adviser (IFA).

Key Proponents and Rationale
The movement is led by independent investor Ong Chin Woo, representing about 4.5 per cent of UOI’s total shares. Ong, known for his earlier activism at Great Eastern Holdings, argues that UOI’s strong financial ratios demonstrate its capacity to return excess capital without affecting growth. In FY2023, UOI reported a shareholders’ fund to total assets ratio of 70.4 per cent and a capital adequacy ratio of 415 per cent, significantly above industry averages.

The group compared this distribution strategy to a hypothetical special dividend of S$0.67 per share, finding it a more advantageous option that would enhance shareholder value without compromising UOI’s financial stability or growth prospects.

UOI is proposing a final dividend of S$0.085 per share and a special dividend of S$0.06 per share for FY2024. However, the minority shareholders believe the proposed distributions do not fully reflect UOI’s strong financial position and capital adequacy.

Strategic Implications and Next Steps
UOI and Haw Par are part of a group of companies controlled by the Wee family behind United Overseas Bank (UOB). UOB has a 58 per cent interest in UOI. The resolutions highlight growing shareholder activism and governance scrutiny within family-controlled conglomerates.

The proposals will be discussed at UOI’s upcoming AGM, with significant implications for minority shareholders and corporate governance practices.

Thank you

Genting Malaysia’s New Casino: Positive Step but Limited Impact on Earnings

In-Depth Analysis on Genting Malaysia and Related Companies In-Depth Analysis on Genting Malaysia and Related Companies Date of Report: January 6, 2025 Broker Name: Maybank Investment Bank Berhad Overview of the Report The report...

Innovent Biologics: Pharma Giant in the Making with Strong Growth Prospects

Company Highlights: Innovent Biologics is evolving from a biotech company to a major pharmaceutical player in China, driven by its diverse drug pipeline. Key drugs such as Sintilimab, the company’s leading anti-PD-1 antibody, and...

Boustead Singapore (BTSS.SI) 2025 Analysis: Strong Profit Growth, Resilient Dividend & Fair Value Upgrade to SGD1.46

Broker: OCBC Investment Research Date of Report: 29 May 2025 Boustead Singapore: Resilient Profit Growth and Dividend Upside Amid Macroeconomic Uncertainty Overview: A Legacy of Engineering Excellence and Strategic Diversification Boustead Singapore Limited, one...